Latest news
Radiopharmaceutical could benefit metastatic prostate cancer patients sooner - Bioengineer.orgBioengineer.org · Fri, 07 Aug 2026 02:58:49 GMTSNORD18B/SNORD18C-RPL23A Promotes Homologous Recombination Through BRCA1 - Bioengineer.orgBioengineer.org · Fri, 07 Aug 2026 02:38:49 GMTTurning Iron-Dependent Cell Death into Precision Treatments for Prostate Cancer - Bioengineer.orgBioengineer.org · Fri, 07 Aug 2026 02:08:49 GMTTuft Cell-Like Tumors Reveal New Cancer Subtype With Distinct Biology, Treatment Potential - Bioengineer.orgBioengineer.org · Thu, 06 Aug 2026 22:23:49 GMTBlocking MDA-9 slows head and neck tumors and overcomes treatment resistance - Bioengineer.orgBioengineer.org · Wed, 05 Aug 2026 22:43:47 GMTErectile Dysfunction Drug for Enlarged Prostate May Increase Glaucoma Risk - Bioengineer.orgBioengineer.org · Wed, 05 Aug 2026 01:58:21 GMTMD Anderson named nation’s No. 1 cancer center for 12th consecutive year - Bioengineer.orgBioengineer.org · Wed, 05 Aug 2026 00:53:21 GMTUMass Amherst AI tool advances personalized radiation dosing for prostate cancer treatment - Bioengineer.orgBioengineer.org · Tue, 04 Aug 2026 15:18:21 GMT